Marico Limited share price
NSE: MARICO · BSE: 531642 · ISIN INE196A01026
Key numbers
- Market cap
- ₹ 1,06,306 Cr
- Current price
- ₹ 819.00
- 52-week high / low
- ₹ 889 / 690
- Stock P/E
- 56.8
- Book value
- ₹ 32.4
- Dividend yield
- 0.49%
- ROCE
- 49.8%
- ROE
- 43.1%
- Debt to equity
- 0.13
- Sales growth (3 yrs)
- 11.8%
- Profit growth (3 yrs)
- 10.6%
- 1-year return
- 15.8%
About Marico Limited
Marico Limited, together with its subsidiaries, manufactures and sells branded consumer products in India, Bangladesh, Vietnam, and internationally. It offers coconut oils, refined edible oils, hair oils, anti-lice treatments, fabric care, functional and other processed food, hair creams and gels, hair serums, shampoos, conditioners, shower gels, hair relaxers and straighteners, deodorants, female personal care, baby care, skin care, male grooming and hair styling, packaged food, health care, and hygiene products. The company markets its products under the Parachute, Parachute Advansed, Saffola, Hair & Care, Parachute Advansed, Nihar Naturals, Mediker, Pure Sense, Coco Soul, Revive, Set Wet, Livon, Just Herbs, True Elements, Kaya, Beardo, and Plix, HairCode, Fiancée, Purité de Prôvence, Ôliv, Lashe', Caivil, Hercules, Black Chic, Code 10, Ingwe, X-Men, Studio X, Thuan Phat and Isoplus brand names. It sells its products through distribution network, including regional offices, carrying and forwarding agents, redistribution centers, and distributors. Marico Limited was incorporated in 1988 and is headquartered in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 3,221 | 3,482 | 3,537 | 3,333 | 3,957 |
| Operating profit | 655 | 560 | 592 | 521 | 819 |
| Net profit | 504 | 420 | 447 | 391 | 630 |
| EPS (₹) | 3.90 | 3.24 | 3.45 | 3.04 | 4.86 |
Concall summary (2026-08-11)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- We are confident of achieving high -teens EBITDA growth and aspire to touch 20% EBITDA growth during this year.
- I think from a full year perspective, you can take a guidance of about 18% for FY27 and maybe about 19% to 20% for FY28.
Growth & demand
- We have started the year on a very strong note with a consolidated revenue growth of 23% and EBITDA and PAT growth of 25%, making our highest profit growth in the last 28 quarters.
- The India business delivered one of the strongest quarters in recent years with 11% volume growth and revenue growth of 21%, led by robust momentum in core business and continued scale-up of new growth engines.
Margins & costs
- EBITDA margin improved 40 basis points year-on-year to 20.7%.
- Revenue grew 23%, reflecting the anniversarization of prior year price increases and pricing actions done during the quarter as we proactively passed on value to the consumers in non-price point large packs amid softening in copra prices.
Capex & expansion
- My first question is on plant protein, collagen and ACV.
- Having said that, as you know, Plix has also pivoted successfully towards premium personal care, which is plant-based hair and skin food.
Balance sheet & cash
- With an ARR of over INR1,100 crores, the business has scaled up profitably, exemplifying our digital playbook of combining entrepreneurial brand building with disciplined capital allocation and operating leverage.
- We're reducing the share of commodity -linked businesses and progressively shifting our portfolio towards categories that are more profitable.As a result, our portfolio is being designed to compound more profitably with stronger unit economics, lower cyclicity and better operating leverage over time.
Peers in Household & Personal Products
Data for information only, not investment advice. Prices end of day.